DNA Sequence in Pfizer COVID-19 Vaccine Could Spur New Lawsuits
By Zachary Stieber Pfizer and its partner BioNTech could be open to lawsuits for including a DNA sequence in their COVID-19 vaccine. The Public Readiness and Emergency Preparedness Act, known as the PREP Act, largely shields COVID-19 vaccine manufacturers from lawsuits, but companies can be sued for “willful misconduct,” which includes acts taken “intentionally to achieve a wrongful…
More Stories
CVS Health Co. (NYSE:CVS) Shares Bought by Seizert Capital Partners LLC
Seizert Capital Partners LLC raised its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 3.5% during...
PepsiCo, Inc. (NASDAQ:PEP) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC reduced its holdings in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 2.5%...
AM Squared Ltd Has $94,000 Stock Holdings in Target Co. (NYSE:TGT)
AM Squared Ltd trimmed its position in shares of Target Co. (NYSE:TGT – Free Report) by 50.0% during the third...
Marathon Trading Investment Management LLC Purchases New Position in T-Mobile US, Inc. (NASDAQ:TMUS)
Marathon Trading Investment Management LLC acquired a new stake in shares of T-Mobile US, Inc. (NASDAQ:TMUS – Free Report) in...
BMO Capital Markets Forecasts Strong Price Appreciation for Mastercard (NYSE:MA) Stock
Mastercard (NYSE:MA – Free Report) had its price target lifted by BMO Capital Markets from $550.00 to $565.00 in a...
Torex Gold Resources Inc. (TSE:TXG) Director Caroline Donally Purchases 500 Shares
Torex Gold Resources Inc. (TSE:TXG – Get Free Report) Director Caroline Donally acquired 500 shares of the company’s stock in...